Bioniche Mycobacterial Cell Wall Extract (MCWE) Granted New Patent for Production Performance in Animals
The new patent relates to the Company's proprietary composition, Mycobacterial Cell Wall Extract (MCWE). MCWE, a potent immunomodulator, has now been shown to possess the ability to enhance the production performance of an animal. The new patent is entitled: "Method for enhancing production performance in an animal" (U.S. 6,890,541). Dr. Dragan Rogan, Vice-President of Research and Development for Bioniche Animal Health and co-inventor of the patent, noted: "This patent covers a method of activating the immune system of a newborn animal thus enhancing production performance of the animal by using an appropriate dose of MCWE."
The ability of MCWE to boost the immune system in food producing animals thereby enhancing production performance addresses a critical need in the global food production market. "By using this immunomodulatory technology to increase production efficiency, producers will improve their yields in growth without resorting to the traditional method of feeding antibiotics," added Dr. Rogan.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.